Market Tracker

04/17 6:05pm ET

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

4.13
Data as of Apr 17
 +0.03 / +0.73%
Today’s Change
3.92
Today|||52-Week Range
6.65
-12.68%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close4.10
Today’s open4.10
Day’s range4.10 - 4.18
Volume54,902
Average volume (3 months)128,204
Market cap$73.1M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-6.25%
Earnings growth (this year)+11.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,075.41%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CBRXColumbia Laboratorie...-0.04-0.59%
BLRXBioLine RX Ltd+0.01+0.49%
AVEOAveo Pharmaceuticals...-0.05-3.60%
MSTXMast Therapeutics In...+0.01+1.80%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$47.8M
Annual profit (last year)-$39.6M
Net profit margin-82.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Thomas Braxton King
Chief Operations Officer &
Executive VP-Operations
Robert A. Lippe
Corporate headquarters
Mountain View, California

Forecasts